15Dec
11Dec
The whole thing is surreal’: Founder of Framingham-based DetraPel makes Forbes 30 Under 30 list
David Zamarin, founder of Framingham-based DetraPel, was named to the Class of 2021 Forbes 30 Under 30 list. DetraPel Inc., a provider of safer chemicals and consumer products, switched much of its manufacturing capabilities with a pivot to sanitizing and disinfecting products at the beginning of the COVID-19 pandemic. Read more >>
11Dec
Wolf Administration Highlights Development of Promising New Drug Candidate to Treat COVID-19
On Wednesday, Department of Community and Economic Development (DCED) Deputy Secretary Steve D’Ettorre and Ben Franklin Technology Partners Innovation Works Chief Executive Officer Richard Lunak joined Teresa Whalen, CEO of Pittsburgh-based CytoAgents, to highlight the development of a new COVID-19 treatment. “This exciting new development was made possible by the strong partnerships the Wolf Administration has fostered with our Ben Franklin Technology Partners and the companies they support, like CytoAgents,” said D’Ettorre. Read more >>
10Dec
Pittsburgh-based company behind ‘promising’ new COVID-19 treatment
On Wednesday, the Wolf Administration plans to highlight what it calls in a news advisory a “promising new drug candidate to treat COVID-19.” The Department of Community and Economic Development will announce that Pittsburgh-based biotechnology company CytoAgents has begun its Phase 1 clinical trial for COVID-19 treatment. Read more >>
10Dec
All-Star Athletes Across Sports Are Seeing Injury Recovery Without Surgery or Medication Using SAM 2.0 Wearable Ultrasound
ZetrOZ Systems, developers of the Sustained Acoustic Medicine (SAM) wearable ultrasound, an FDA-cleared bio regenerative medical device supported by the National Institutes of Health, announces that the SAM family of medical ultrasound device has received positive reviews and feedback from professional athletes across a number of different sports and disciplines. The medical device's ability to provide relief from muscle injury and pain showcases SAM's ability to deal with the physical rigors of professional sports and is perfect for home use...
10Dec
ClassLink and Scrible Partnership Demonstrates the Benefits of Integrated Technology for School Districts
As easy access to digital resources grows increasingly critical to learning, the new ClassLink and Scrible partnership demonstrates how interoperability and open standards support remote and hybrid learning. ClassLink, the leading single sign-on platform for education, and Scrible, an advanced research and writing platform, now integrate using open standards. Read more >>
10Dec
How CytoAgents’ plans for growth run far beyond Covid crisis
GP1681 “has the potential to be the next best practice in medicine in areas with significant unmet need,” CytoAgents CEO Teresa Whalen said. Out clinical trials as well as plans for growth to include other uses for the dreuge. CytoAgents is working in Australia with its partner, Novotech, on the phase one clinical trial of GP1681...Read more >>
10Dec
Emovi, Inc. Announces Partnership with Sports Illustrated as Key Sponsor for The Sports Illustrated Awards
Emovi, Inc., a global medical device developer, today announced a partnership with Sports Illustrated as a sponsor of the 2020 Sports Illustrated Awards (SI Awards). The SI Awards will take place in Las Vegas on December 19. Viewers can stream the primetime broadcast live via the Sports Illustrated Facebook page beginning at 7:00 PM ET.Read more >>
09Dec
Wasabi Named an Outperformer in GigaOm Radar for Alternatives to Amazon AWS S3
Wasabi, the hot cloud storage company, has been named an “outperformer” in the new report, “GigaOm Radar for Alternatives to Amazon AWS S3.” GigaOm evaluated 11 cloud storage vendors based on common metrics related to Amazon AWS S3 including cost-predictability, performance, multi-cloud environment, and lock-in avoidance. Vendors were then categorized by execution, roadmap, and ability to innovate. Read more >>
08Dec